Neurosciences articles for Stanford University, United States of America (USA)

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 50

Article ‘Count’ for Neurosciences.

Journal Count Share
1 0.03
Enhancing Thrombolysis Safety in Post-Acute Ischemic Stroke with Tissue Plasminogen Activator-Associated Microparticles 0.03
6 0.43
Using Expert‐Cited Features to Detect Leg Dystonia in Cerebral Palsy 0.06
Thrombectomy versus Medical Management for Pediatric Acute Ischemic Stroke Due to Isolated M2 Occlusion: A Multicenter Cohort Study 0.04
Mutations in the Key Autophagy Tethering Factor scpEPG5/scp Link Neurodevelopmental and Neurodegenerative Disorders Including Early‐Onset Parkinsonism 0.01
Intravenous Glyburide in Medical and Endovascular‐Treated Large‐Core Stroke: A Subgroup Analysis of the scpCHARM/scp Randomized Clinical Trial 0.06
Chronic Striatal Cholinergic Interneuron Excitation Causes Cerebral Palsy‐Related Dystonic Behavior in Mice 0.05
Intravenous Thrombolysis Use before Inter‐Facility Transfer for Thrombectomy: Association with Efficacy and Safety Outcomes 0.22
1 0.05
Association of Polytrauma Care and Primary Care with Utilization of Health Services for Veterans with Traumatic Brain Injury 0.05
2 0.07
Brain atrophy patterns in anti-IgLON5 disease 0.03
Charcot-Marie-Tooth disease type 1E: clinical natural history and molecular impact of iPMP22/i variants 0.04
3 1.18
Fronto-insular circuit mechanisms of accelerated intermittent theta burst stimulation 0.06
Cell-type resolved protein atlas of brain lysosomes identifies SLC45A1-associated disease as a lysosomal disorder 0.60
The effect of shingles vaccination at different stages of the dementia disease course 0.52
1 0.14
Early Relative Hypotension Below Noninvasive Cerebral Oximetry-Derived Optimal Blood Pressure Thresholds in Aneurysmal Subarachnoid Hemorrhage: A Pilot Study. 0.14
1 0.71
Distinct neural representations of hunger and thirst in neonatal mice before the emergence of food- and water-seeking behaviors 0.71
1 0.87
Targeting immune cells in the aged brain reveals that engineered cytokine IL-10 enhances neurogenesis and improves cognition 0.87
3 0.10
Levodopa Added to Stroke Rehabilitation 0.01
Alteplase for Acute Ischemic Stroke at 4.5 to 24 Hours 0.04
Influenza-Associated Acute Necrotizing Encephalopathy in US Children 0.05
1 0.06
Spinal Fusion in Patients with GMFCS IV or V Cerebral Palsy: Durable Correction and Lasting Quality of Life Improvements: Five-Year Multicenter Outcomes. 0.06
1 1.00
Aggregation shifts amyloid-β peptides from synaptogenic to synaptotoxic 1.00
1 0.27
Salience Signaling and Stimulus Scaling of Ventral Tegmental Area Glutamate Neuron Subtypes 0.27
1 0.04
Electric Double Layer Phenomena Near Surfaces Irreversibly Trigger Assembly of Tau Protein 0.04
1 0.43
Characterization of National Institute on Aging‐Funded Clinical Trials for Alzheimer's Disease 0.43
5 3.52
Deconstruction of a spino-brain–spinal cord circuit that drives chronic pain 1.00
Magnetic resonance control of spin-correlated radical pair dynamics in vivo 0.83
Ageing promotes microglial accumulation of slow-degrading synaptic proteins 0.64
A parabrachial hub for need-state control of enduring pain 0.04
Milli-spinner thrombectomy 1.00
1 1.00
Clearance of intracranial debris by ultrasound reduces inflammation and improves outcomes in hemorrhagic stroke models 1.00
8 2.08
elective and differential roles of PVHCRH neurotransmitters in diet-induced obesity in mice 0.07
Dopamine and serotonin inversely modulate D2 medium spiny neurons to regulate cocaine reward 0.88
Rapid modulation of choice behavior by ultrasound on the human frontal eye fields 0.06
A radiolabeled dendrimer non-invasively identifies and tracks innate immune cell activation in a mouse model of experimental autoimmune encephalomyelitis 0.79
The glymphatic system clears amyloid beta and tau from brain to plasma in humans 0.07
Chronic cerebral hypoperfusion induces venous dysfunction via EPAS1 regulation in mice 0.09
Intraoperative nerve-specific fluorescence visualization in head and neck surgery: a Phase 1 trial 0.11
Reduction of neuronal activity mediated by blood-vessel regression in the adult brain 0.01
1 0.80
Spatial proteomics of Alzheimer’s disease-specific human microglial states 0.80
2 0.79
High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial 0.05
Disruption of the cerebrospinal fluid–plasma protein balance in cognitive impairment and aging 0.74
1 0.03
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, genotype and sex 0.03
5 2.35
Cytotoxic T cell recognition of α-synuclein drives pathogenic immune responses in multiple system atrophy 0.42
MBNL loss of function in smooth muscle as a model for myotonic dystrophy associated gastrointestinal dysmotility 0.11
Full interhemispheric integration sustained by a fraction of posterior callosal fibers 0.02
Geometrical compartmentalization of trigger waves 0.80
Actions of the antiseizure drug carbamazepine in the thalamic reticular nucleus: Potential mechanism of aggravating absence seizures 1.00
1 0.63
Calcium-based synaptic and structural plasticity link pathological activity to synaptic reorganization in Parkinson’s disease 0.63
1 0.04
Safety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trial 0.04
1 0.05
An Antibody–Oligonucleotide Conjugate for Myotonic Dystrophy Type 1 0.05

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.